Tech Company Financing Transactions
Exela Pharma Sciences Funding Round
On 6/30/2008, Exela Pharma Sciences raised $6.3 million in financing from Presidio Partners.
Transaction Overview
Company Name
Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
$6,250,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1245 Blowing Rock Blvd.
Lenoir, NC 28645
USA
Lenoir, NC 28645
USA
Phone
Website
Email Address
Overview
Exela develops and manufactures both innovative and generic injectable and ophthalmic pharmaceutical products, providing excellence in sterile products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Phanesh Koneru
Chief Scientific Officer
SR Mallipeddi
Vice President
Gary Brennan
VP - Bus. Development
Mark Hartman
VP - R & D
John Maloney
Browse more venture capital transactions:
Prev: 6/30/2008: InboundWriter venture capital transaction
Next: 6/30/2008: Whaleback Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs